123
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Treatment intensity and survival in patients with relapsed or refractory diffuse large B-cell lymphoma in Denmark: a real-life population-based study

, , , , , & show all
Pages 207-216 | Published online: 04 Mar 2019

References

  • CoiffierBThieblemontCVan Den NesteELong-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d’Etudes des Lymphomes de l’AdulteBlood2010116122040204520548096
  • PfreundschuhMTrümperLÖsterborgACHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) GroupLancet Oncol20067537939116648042
  • SehnLHDonaldsonJChhanabhaiMIntroduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British ColumbiaJ Clin Oncol200523225027503315955905
  • PhilipTGuglielmiCHagenbeekAAutologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphomaN Engl J Med199533323154015457477169
  • FriedbergJWRelapsed/refractory diffuse large B-cell lymphomaHematology Am Soc Hematol Educ Program20112011149850522160081
  • MartelliMFerreriAJAgostinelliCDi RoccoAPfreundschuhMPileriSADiffuse large B-cell lymphomaCrit Rev Oncol Hematol201387214617123375551
  • GisselbrechtCIs there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?Hematology Am Soc Hematol Educ Program2012201241041623233612
  • GisselbrechtCGlassBMounierNSalvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab eraJ Clin Oncol201028274184419020660832
  • MounierNCanalsCGisselbrechtCHigh-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European blood and marrow transplantation registryBiol Blood Marrow Transplant201218578879322005647
  • LukenbillJHillBRelapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patientsLeuk Lymphoma201556229330024813764
  • FrederiksenBLDaltonSOOslerMSteding-JessenMde Nully BrownPSocioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide studyBr J Cancer2012106598899522315055
  • HongSRybickiLAbounaderDMAssociation of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphomaNat Publ Gr201651911911196
  • ArboeBJosefssonPJørgensenJDanish national lymphoma registryClin Epidemiol2016857758127822102
  • ArboeBEl-GalalyTCClausenMRThe Danish national lymphoma registry: coverage and data qualityPLoS One2016116e015799927336800
  • SchmidtMSchmidtSASandegaardJLEhrensteinVPedersenLSørensenHTThe Danish National Patient Registry: a review of content, data quality, and research potentialClin Epidemiol2015744949026604824
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • JensenVMRasmussenAWDanish education registersScand J Public Health2011397 Suppl919421775362
  • BaadsgaardMQuitzauJDanish registers on personal income and transfer paymentsScand J Public Health2011397 Suppl10310521775365
  • TherneauTMA package for survival analysis in R2015 Available from: https://cran.r-project.org/package=survivalAccessed December 7, 2018
  • RipleyBVenablesWModern Applied Statistics with S Fourth EditionNew YorkSpringer2002 Available from: http://www.stats.ox.ac.uk/pub/MASS4Accessed December 7, 2018
  • SmithSDBolwellBJRybickiLAComparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximabBone Marrow Transplant201146226226620479706
  • HamadaniMHariPNZhangYEarly failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantationBiol Blood Marrow Transplant201420111729173625008330
  • WildesTMAugustinKMSempekDComorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphomaBiol Blood Marrow Transplant200814784084618541205
  • GrafSAVaughnJEChaunceyTRComorbidities, alcohol use disorder, and age predict outcomes after autologous hematopoietic cell transplantation for LymphomaBiol Blood Marrow Transplant20162291582158727311969
  • GreenSBByarDPUsing observational data from registries to compare treatments: the fallacy of omnimetricsStat Med1984343613706396792